Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07552922
What this trial is testing

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Who this might be right for
Prostate Cancer (Adenocarcinoma)
St Vincent's Hospital, Sydney 24
Early research (Phase 1)Study completedNCT02100553
What this trial is testing

Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women

Who this might be right for
Healthy
Pfizer 24
Not applicableStudy completedNCT02197000
What this trial is testing

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

Who this might be right for
BRCA1 Gene MutationBRCA2 Gene Mutation
Rabin Medical Center 23
Not applicableStudy completedNCT02226302
What this trial is testing

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Queensland Centre for Gynaecological Cancer 16
Testing effectiveness (Phase 2)Study completedNCT00001253
What this trial is testing

The Effects of Estrogen on Cognition in Girls With Turner Syndrome

Who this might be right for
Gonadal DysgenesisTurner's Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 950
Testing effectiveness (Phase 2)Ended earlyNCT00141557
What this trial is testing

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

Who this might be right for
Menopause
Solvay Pharmaceuticals 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT06428396
What this trial is testing

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

Who this might be right for
Metastatic Breast Cancer
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)Study completedNCT00003199
What this trial is testing

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more
Fred Hutchinson Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06065748
What this trial is testing

Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Who this might be right for
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche 1,050
Not applicableActive Not RecruitingNCT05309655
What this trial is testing

Cardiac Outcomes With Near-Complete Estrogen Deprivation

Who this might be right for
Breast CancerTriple Negative Breast CancerCardiovascular Complications
Duke University 90
Not applicableWithdrawnNCT05051293
What this trial is testing

Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension

Who this might be right for
HypotensionCirrhosis
Methodist Health System
Not applicableNot Yet RecruitingNCT06623903
What this trial is testing

Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy

Who this might be right for
Early Breast CancerMetabolic HealthEstrogen Receptor Positive Breast Cancer
Aarhus University Hospital 112
Post-approval studies (Phase 4)Active Not RecruitingNCT04255160
What this trial is testing

Impact of Estradiol on Endothelial Function in Peri-Menopausal Women

Who this might be right for
PerimenopauseVasodilationEstrogen
University of Delaware 80
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Post-approval studies (Phase 4)Study completedNCT00227942
What this trial is testing

Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia

Who this might be right for
Sleep Initiation and Maintenance DisordersDepression
Hadine Joffe, MD 86
Testing effectiveness (Phase 2)Ended earlyNCT03172533
What this trial is testing

Estrogen Replacement in Anorexia Nervosa

Who this might be right for
Anorexia Nervosa
University of Erlangen-Nürnberg Medical School 11
Not applicableActive Not RecruitingNCT06805084
What this trial is testing

Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas

Who this might be right for
Breast AdenocarcinomaLuminal B Breast Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Testing effectiveness (Phase 2)Study completedNCT01997333
What this trial is testing

Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

Who this might be right for
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
Celldex Therapeutics 327
Not applicableEnrolling By InvitationNCT06629233
What this trial is testing

Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.

Who this might be right for
Estrogen Receptor Positive Breast Cancer
University Ghent 36
Not applicableLooking for participantsNCT04476485
What this trial is testing

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

Who this might be right for
Breast Cancer
Shengjing Hospital 1,000
Next Page